VISCERAL ADIPOSITY INFLUENCES THE ANTIVIRAL EFFECT OF PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT FOR REFRACTORY CHRONIC HEPATITIS C

被引：0
|
作者：
Mizuta, Toshihiko [1 ]
Kawaguchi, Yasunori [1 ]
Eguchi, Yuichiro [1 ]
Takahashi, Hirokazu [1 ]
Iwane, Shinji [1 ]
Kuwashiro, Takuya [1 ]
Oeda, Satoshi [1 ]
Isoda, Hiroshi [1 ]
Ozaki, Iwata [1 ]
机构：
[1] Saga Madical Sch, Saga, Japan
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
926
引用
收藏
页码：766A / 767A
页数：2
相关论文
共 50 条
  • [1] Muscle adiposity influences viral response to pegylated interferon plus ribavirin treatment in patients with genotype 1 chronic hepatitis C
    Okada, Michiaki
    Mizuta, Toshihiko
    Kitajima, Yoichiro
    Kawaguchi, Yasunori
    Iwane, Shinji
    Ide, Yasushi
    Eguchi, Yuichiro
    Anzai, Keizo
    Ozaki, Iwata
    [J]. HEPATOLOGY, 2013, 58 : 1152A - 1152A
  • [2] Antiviral effect of ribavirin plus interferon in chronic hepatitis C
    Ciccorossi, P
    Ricchiuti, A
    Petruccelli, S
    Costa, F
    Bellini, M
    Arpe, P
    Carrara, PD
    Maggi, F
    Vatteroni, L
    Pistello, M
    Bendinelli, M
    Maltinti, G
    Marchi, S
    [J]. HEPATOLOGY, 1998, 28 (04) : 474A - 474A
  • [3] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    [J]. Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [4] The therapeutic effect of ribavirin plus pegylated interferon in chronic hepatitis B and C
    Chien, Rong-Nan
    Hu, Ching-Chih
    Sheen, I-Shyan
    Liaw, Yun-Fan
    Yen, Cho-Li
    Chang, Jia-Jang
    [J]. HEPATOLOGY, 2006, 44 (04) : 341A - 341A
  • [5] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [6] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    [J]. DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [7] Pegylated intron a plus ribavirin for treatment of patients with Rebetron refractory chronic hepatitis C
    Hyun, CB
    Brann, OS
    Hassanein, TI
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S103 - S103
  • [8] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    [J]. HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [9] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    [J]. Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [10] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
12345